| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.509 | 4.217 | 2.454 | 2.439 | 2.426 | 342 |
| Total Income - EUR | - | - | - | - | 3.509 | 6.310 | 6.695 | 6.693 | 6.440 | 47.828 |
| Total Expenses - EUR | - | - | - | - | 892 | 17.238 | 31.007 | 29.054 | 19.617 | 26.802 |
| Gross Profit/Loss - EUR | - | - | - | - | 2.617 | -10.928 | -24.312 | -22.361 | -13.177 | 21.025 |
| Net Profit/Loss - EUR | - | - | - | - | 2.512 | -10.970 | -24.337 | -22.385 | -13.201 | 20.772 |
| Employees | - | - | - | - | 0 | 3 | 4 | 4 | 2 | 1 |
Check the financial reports for the company - Art Overdose 23 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 22 | 33.971 | 28.977 | 24.803 | 20.713 | 0 |
| Current Assets | - | - | - | - | 2.855 | 45.017 | 40 | 7 | 48 | 32 |
| Inventories | - | - | - | - | 0 | 3.469 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 41.175 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | - | 2.855 | 373 | 40 | 7 | 48 | 32 |
| Shareholders Funds | - | - | - | - | 2.530 | -8.488 | -32.636 | -55.122 | -68.156 | -47.003 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 347 | 48.609 | 27.845 | 50.235 | 63.195 | 47.035 |
| Income in Advance | - | - | - | - | 0 | 39.083 | 33.976 | 29.828 | 25.723 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9002 - 9002" | |||||||||
| CAEN Financial Year |
9002
|
|||||||||
Comments - Art Overdose 23 S.r.l.